ARTICLE | Company News
EnBioTec Laboratories Co. Ltd., Tripos deal
November 6, 2006 8:00 AM UTC
The companies partnered to develop nuclear receptor-based compounds for an undisclosed indication. EnBioTec will use its Receptor Cofactor Assay System (RCAS) to evaluate interactions between nuclear ...